person

Isabel F.

Country
Spain
Department
Anaesthesiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 11 partner sites.

Specializations

Oncologic Therapeutics

Focused on targeted and immunologic strategies for breast cancer, non‑small cell lung cancer, and colorectal cancer.

  • HER2‑positive and HER2‑negative disease subtypes
  • PIK3CA‑mutated tumor pathways
  • RET fusion‑positive lung malignancies
  • Sequencing of biologic agents with chemotherapy

Efforts aim to refine adjuvant and metastatic treatment landscapes.

Peri‑operative Pain Management

Investigation of analgesic interventions to prevent chronic postsurgical pain after abdominal and hernia procedures.

  • Duloxetine for high‑risk inguinal hernia repair
  • Multimodal analgesia protocols
  • Assessment of functional recovery metrics

Emphasis is placed on opioid‑sparing approaches.

Gastrointestinal Surgical Outcomes

Addresses complications such as esophagojejunal anastomosis dehiscence and postoperative urinary infections.

  • Fibrin‑based adhesives in total gastrectomy
  • Indocyanine green fluorescence for bile duct visualization
  • Clinical cure criteria for acute bacterial prostatitis

Research integrates intra‑operative imaging and biomaterial innovations.

Psychiatric Precision Medicine

Explores biomarker‑driven treatment for schizophrenia and first‑episode psychosis.

  • Multi‑omics profiling for antipsychotic response
  • Comparative efficacy of aripiprazole and paliperidone
  • Long‑term discontinuation risk assessment

Goals include personalized medication selection.

Cardiovascular & Metabolic Risk

Targets prevention of major adverse events in patients with ASCVD and related risk factors.

  • Evaluation of novel PI3K inhibitors in high‑risk cohorts
  • Assessment of major adverse cardiovascular events (MACE)
  • Integration of endocrine therapy with CDK4/6 inhibition

Studies aim to reduce cardiovascular morbidity through therapeutic innovation.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.